Speciality Medicines IPO
Speciality Medicines IPO is a book built issue of ₹23,50,000 crores. The issue is entirely a fresh issue. The subscription opens on 20 Mar '26 and closes on 24 Mar '26, with the basis of allotment expected to be finalised on 25 Mar '26. The shares are scheduled to list on BSE with a tentative listing date fixed for 30 Mar '26. The price band is set at ₹117 to ₹124 per share with a minimum lot size of 1,000 shares. Unistone Capital Pvt Ltd is the book-running lead manager, while Skyline Financial Services Pvt Ltd is the registrar of the issue; for detailed information, refer directly to the official Speciality Medicines IPO .
Free Demat with Zero AMC*
Speciality Medicines IPO Subscription Breakdown
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 0% | -- |
| Non-Institutional Investors (NIIs) | 50% | 11,75,000 crores |
| Retail Individual Investors (RIIs) | 50% | 11,75,000 crores |
About Speciality Medicines Ltd IPO
Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals — including high-cost oral and injectable medications used to treat complex chronic conditions — across both domestic and international markets.
The company’s portfolio includes a wide range of speciality pharmaceutical finished formulations products, which are available in various dosage forms such as tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company operates via two models: (a) contract manufacturing of finished formulations for international distribution, and (b) marketing and distribution of sourced specialty pharmaceutical products.
The company has expanded internationally with registered or pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. Its distribution network builds strong relationships across over 20 states in India and more than 35 countries worldwide world.
As of Feb 28, 2026, the company has 7 products registered overseas and 54 products are in the registration process across 5 countries.
Speciality Medicines IPO Strengths & Weaknesses
Diversified Global Presence
Diversified Product Portfolio
Long Standing Client Relationship
Experienced Promoters and Management Team
Quality Assurance
Speciality Medicines IPO Issue Details
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 23,50,000 shares (aggregating up to ₹2,48,000 crores) |
| Fresh Issue | 2,20,000 shares (aggregating up to ₹22,00,000 crores) |
| Offer for Sale | 0 shares of ₹10 (aggregating up to To be announced) |
| Issue Type | Bookbuilding IPO |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 6435796 shares |
| Post-Issue Shareholding | 8785796 shares |
Speciality Medicines IPO Shares
| Minimum Shares | Maximum Shares |
|---|---|
| -- | -- |
The lot size of Speciality Medicines ipo has been designed to ensure broad participation while maintaining optimal price discovery.
How to Apply for Speciality Medicines IPO
- Log in to your Choice account
- Select IPO
- Enter the number of lots and your price
- Verify UPI ID
- Complete the transaction on your UPI app
Speciality Medicines IPO Contact & Registrar Details
Contact Details
Address
913 One World West S No 396 FP 119 Village Vejalpur Ahmadabad City Ahmedabad
Phone Number
Registrar Details
Registrar Name
Skyline Financial Services Pvt Ltd
Phone Number
Speciality Medicines Lead Manager(s)
| Book Running Lead Manager(s) |
|---|
| Unistone Capital Pvt Ltd |
